ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 144,82
1,16%
Dow Jones
43 621,16
0,37%
DAX
22 713,53
1,42%
Brent Oil
72,56
-0,04%
Bitcoin
88 837,40
0,23%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Neurocrine Biosciences Inc (NBIX) Cours

Neurocrine Biosciences Inc

Neurocrine Biosciences Inc (NBIX)

NASDAQ
115,90
-3,21
(-2,69%)
Fermé 26 Février 10:00PM
Retardé de 15 minutes
115,90
0,00
( 0,00% )
Avant marché: 12:12PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
115,90
Prix Achat
110,00
Prix Vente
116,16
Volume échangé
808
0,00 Fourchette du Jour 0,00
110,95 Plage de 52 semaines 157,9799
Cap du marché
11,556B
Clôture Veille
115,90
Ouverture
-
Dernière Transaction
1
@
116.8
Dernière heure de transaction
12:01:00
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 234 429
Actions en circulation
99 703 527
Rendement du Dividende
-
Ratio Cours sur Bénéfices
33,86
Bénéfice par action (BPA)
3,42
Chiffre d'affairess
2,36B
Bénéfice net
341,3M

À propos de Neurocrine Biosciences Inc

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is a... Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.neurocrine.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Neurocrine Biosciences Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker NBIX. Le dernier cours de clôture d'Neurocrine Biosciences était de US$115,90. Au cours de la dernière année, les actions de Neurocrine Biosciences ont été négociées dans une fourchette de prix de US$ 110,95 à US$ 157,9799.

Neurocrine Biosciences compte actuellement 99 703 527 actions en circulation. La capitalisation boursière d'Neurocrine Biosciences est de US$11,56 milliard. Neurocrine Biosciences a un ratio cours/bénéfice (ratio PE) de 33.86.

Flux d'options Neurocrine Biosciences (NBIX)

Voir le flux d'options complet

Flux global

Baissier

Prime nette

-301k

Calls / Puts

0.00%

Ach. / Vent.

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

NBIX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Février 2025
NBIX (-2,69%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
12.342.06058471293113.56122.371131408908117.65874547CS
4-34.46-22.9183293429150.36154.611131701146125.73191657CS
12-9.57-7.62732127202125.47154.611131234429131.97560082CS
26-37.23-24.3126755045153.13154.61110.951108872126.432233CS
52-18.35-13.6685288641134.25157.9799110.95962530132.09769082CS
15629.07533.486898934686.825157.979975.25820316116.61297274CS
26020.5221.513944223195.38157.979971.875835263109.21162768CS

NBIX - Frequently Asked Questions (FAQ)

What is the current Neurocrine Biosciences share price?
The current share price of Neurocrine Biosciences is US$ 115,90
How many Neurocrine Biosciences shares are in issue?
Neurocrine Biosciences has 99 703 527 shares in issue
What is the market cap of Neurocrine Biosciences?
The market capitalisation of Neurocrine Biosciences is USD 11,56B
What is the 1 year trading range for Neurocrine Biosciences share price?
Neurocrine Biosciences has traded in the range of US$ 110,95 to US$ 157,9799 during the past year
What is the PE ratio of Neurocrine Biosciences?
The price to earnings ratio of Neurocrine Biosciences is 33,86
What is the cash to sales ratio of Neurocrine Biosciences?
The cash to sales ratio of Neurocrine Biosciences is 4,91
What is the reporting currency for Neurocrine Biosciences?
Neurocrine Biosciences reports financial results in USD
What is the latest annual turnover for Neurocrine Biosciences?
The latest annual turnover of Neurocrine Biosciences is USD 2,36B
What is the latest annual profit for Neurocrine Biosciences?
The latest annual profit of Neurocrine Biosciences is USD 341,3M
What is the registered address of Neurocrine Biosciences?
The registered address for Neurocrine Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Neurocrine Biosciences website address?
The website address for Neurocrine Biosciences is www.neurocrine.com
Which industry sector does Neurocrine Biosciences operate in?
Neurocrine Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
QVCGBQVC Group Inc
US$ 14,62
(187,80%)
1,5M
ENVBEnveric Biosciences Inc
US$ 2,69
(127,97%)
16,66M
PITAHeramba Electric PLC
US$ 0,7206
(95,28%)
13,11M
JCTCJewett Cameron Trading Company
US$ 7,64
(64,30%)
63
HCTIHealthcare Triangle Inc
US$ 0,6102
(60,58%)
14,59M
ADVMAdverum Biotechnologies Inc
US$ 1,73
(-58,81%)
21
CSPICSP Inc
US$ 9,12
(-41,87%)
12
SRBKSR Bancorp Inc
US$ 7,01
(-41,83%)
9
BSMWInvesco BulletShares 2032 Municipal Bond ETF
US$ 15,01
(-40,48%)
1
CSBRChampions Oncology Inc
US$ 6,06
(-36,74%)
5
ENVBEnveric Biosciences Inc
US$ 2,69
(127,97%)
16,66M
HCTIHealthcare Triangle Inc
US$ 0,6102
(60,58%)
14,59M
PITAHeramba Electric PLC
US$ 0,7206
(95,28%)
13,11M
ONVOOrganovo Holdings Inc
US$ 1,53
(20,47%)
6,36M
QVCGAQVC Group Inc
US$ 0,4269
(11,17%)
5,13M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
NBIX
Neurocrine Biosciences
BIT
UV8B6H
UniCredit Bank
BIT
S30582
Societe Generale Effekten
BOV
BSOC39R
Global X Funds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces